Additional file 1 of Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas

Additional file 1: Figure S1. Methods to distinguish the T-follicular helper (Tfh) phenotype by CD21 and Tfh markers (CD4, PD-1, CXCL13, BCL6, and CD10) staining (a), methods to classify PTCL-GATA3 (T-helper 2 like origin) and PTCL-TBX21(T-helper 1 like origin) (b). Figure S2. Comparison of OS between PTCL-GATA3 (T-helper 2 like origin) and PTCL-TBX21(T-helper 1 like origin). Figure S3. Matching results of genetic information and TBX21/GATA3 staining.补充文件1：图S1。(a) 通过CD21及滤泡辅助性T细胞（T-follicular helper，Tfh）标记物（CD4、PD-1、CXCL13、BCL6与CD10）染色区分滤泡辅助性T细胞表型的方法；(b) 外周T细胞淋巴瘤（Peripheral T-cell Lymphoma，PTCL）-GATA3（T辅助细胞2型样起源）与PTCL-TBX21（T辅助细胞1型样起源）的分型方法。图S2。PTCL-GATA3（T辅助细胞2型样起源）与PTCL-TBX21（T辅助细胞1型样起源）的总生存期（Overall Survival，OS）对比分析。图S3。基因信息与TBX21、GATA3染色结果的匹配分析。